Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase

Tectonic Therapeutic (NASDAQ:TECX) saw unusually-high trading volume on Tuesday . Approximately 35,556 shares were traded during trading, an increase of 52% from the previous session’s volume of 23,456 shares.The stock last traded at $15.90 and had previously closed at $15.90.

Analysts Set New Price Targets

TECX has been the subject of a number of research analyst reports. TD Cowen assumed coverage on Tectonic Therapeutic in a research report on Monday, June 24th. They set a “buy” rating for the company. Piper Sandler initiated coverage on shares of Tectonic Therapeutic in a research note on Wednesday, June 26th. They issued an “overweight” rating and a $76.00 price objective for the company.

Tectonic Therapeutic Trading Down 0.9 %

The firm has a market capitalization of $704.32 million, a PE ratio of 22.80 and a beta of 2.55.

Tectonic Therapeutic (NASDAQ:TECX) last issued its earnings results on Thursday, May 9th. The company reported ($0.15) earnings per share (EPS) for the quarter. Analysts predict that Tectonic Therapeutic will post -5 earnings per share for the current fiscal year.

About Tectonic Therapeutic

Avrobio, Inc is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc is based in MA, United States.